Lebenthal Holdings’s AbbVie ABBV Stock Holding History

Lebenthal Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$9.23M	Buy	149,030 +83,797	+128%	+$5.11M	1.15%	14
2016 Q1	$3.73M	Buy	65,233 +37,851	+138%	+$2.11M	0.65%	40
2015 Q4	$1.62M	Sell	27,382 -603	-2%	-$34.7K	0.38%	105
2015 Q3	$1.52M	Buy	27,985 +838	+3%	+$54.5K	0.35%	119
2015 Q2	$1.83M	Buy	27,147 +18,171	+202%	+$1.19M	0.37%	114
2015 Q1	$525K	Sell	8,976 -5,006	-36%	-$302K	0.12%	214
2014 Q4	$915K	Buy	+13,982	New	+$881K	0.4%	70

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lebenthal Holdings's ABBV Position: Q2 2016 in Review

Lebenthal Holdings increased its AbbVie (ABBV) stake by 128% in Q2 2016, buying an estimated $5.11M and bringing the position to 149,030 shares worth $9.23M. The position accounts for 1.15% of the portfolio, ranked #14.

Lebenthal Holdings first reported a position in ABBV in Q4 2014 and has held it in 7 quarters since. 1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

Lebenthal Holdings held 149,030 shares of AbbVie worth $9.23M as of Q2 2016.
Lebenthal Holdings bought 83,797 AbbVie shares in Q2 2016, an estimated $5.11M.
AbbVie made up 1.15% of Lebenthal Holdings's portfolio in Q2 2016, its #14 holding.
Lebenthal Holdings first reported a position in AbbVie in Q4 2014 and has held it in 7 quarters since.
1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.